159 results on '"Innes, Andrew J."'
Search Results
2. Author Correction: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
3. FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
4. Allogeneic Hematopoietic Cell Transplantation in CML: When and How?
5. The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
6. COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
7. 3-Deazaadenosine alleviates senescence to promote cellular fitness and cell therapy efficiency in mice
8. Sustainable remediation of abandoned lead mine tailings
9. Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in patients with polycythemia vera (PV).
10. Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
11. Promoter‐centred chromatin interactions associated with EVI1 expression in EVI1+3q− myeloid leukaemia cells
12. Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm
13. Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
14. Outcomes and Characteristics of Non-Melanoma Skin Cancers in Patients with Myeloproliferative Neoplasms on Ruxolitinib
15. Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality
16. Cardiac glycosides are broad-spectrum senolytics
17. Biomedical Research in Aging
18. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
19. Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib
20. IMR90 ER:RAS: A Cell Model of Oncogene-Induced Senescence
21. COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
22. Disease Characteristics and Outcomes of Non-Melanoma Skin Cancers in Myeloproliferative Neoplasm (MPN) Patients Treated with Ruxolitinib
23. Real-World Experience of Asciminib: Factors Associated with Response
24. Total Body Irradiation Is Associated with Higher Prevalence of Cerebral Microbleeds in Haematopoietic Stem Cell Transplant Survivors
25. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
26. Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study
27. Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors
28. Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial
29. Allogeneic transplantation for CML in the TKI era: striking the right balance
30. Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation
31. 811 FECAL MICROBIOTA TRANSPLANT PRIOR TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN PATIENTS COLONIZED WITH MULTI-DRUG RESISTANT ORGANISMS IS ASSOCIATED WITH IMPROVED SURVIVAL
32. Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors.
33. XPO7 is a tumor suppressor regulating p21CIP1-dependent senescence
34. Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia
35. Ruxolitinib for tocilizumab‐refractory severe COVID‐19 infection
36. Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms
37. 1144 FECAL MICROBIOTA TRANSPLANT FOR MULTI-DRUG RESISTANT ORGANISMS: IMPROVED CLINICAL OUTCOMES BEYOND INTESTINAL DECOLONISATION
38. A Multispecies Cluster of GES-5 Carbapenemase–Producing Enterobacterales Linked by a Geographically Disseminated Plasmid
39. Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.
40. Towards a Better Understanding of Cohesin Mutations in AML
41. Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality
42. Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies
43. A Multispecies Cluster of GES-5 Carbapenemase–Producing Enterobacterales Linked by a Geographically Disseminated Plasmid.
44. Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality [Letter to the Editor]
45. Red cell fragments can mask severe thrombocytopenia
46. Immunosuppression-associated Kaposi sarcoma following stem cell transplantation
47. BKV‐specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA‐haploidentical haematopoietic cell transplantation
48. Incidence, Interpretation and Management of Liver Function Abnormalities in Patients with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKI)
49. Allogeneic transplantation for CML in the TKI era: striking the right balance
50. Erratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.